Huashan Shi

15PUBLICATIONS
40CO-AUTHORS
Biological adaptationCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityInnate immunityMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 30, 2026
Aromaticity at spike position 456 affects functional immunogenicity of SARS-CoV-2 Omicron variant receptor-binding domain.

|Sep 30, 2026
Carbon nanoparticle-Fe (II) complex for ferroptosis therapy in refractory solid tumors: a phase I trial.

|Aug 06, 2025
Immunosenescence: signaling pathways, diseases and therapeutic targets.

Yichu Fu, Binhan Wang, Aqu Alu

|Mar 03, 2025
Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma.

Hong-Shuai Li, Ruo Tang, Hua-Shan Shi

|Feb 25, 2025
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants.

Jingyun Yang, Weiqi Hong, Huashan Shi

|Jan 27, 2025
Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages.

Jingyun Yang, Xuemei He, Huashan Shi

Pageof 3

Frequent Collaborators

3 joint publications

Weiqi Hong

3 joint publications

Guangwen Lu

3 joint publications

Aqu Alu

3 joint publications

Jiong Li